Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 303

1.

18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease-A Proof-of-Concept Study.

Schniering J, Benešová M, Brunner M, Haller S, Cohrs S, Frauenfelder T, Vrugt B, Feghali-Bostwick C, Schibli R, Distler O, Müller C, Maurer B.

Front Immunol. 2019 Nov 22;10:2724. doi: 10.3389/fimmu.2019.02724. eCollection 2019.

2.

Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension.

Xanthouli P, Jordan S, Milde N, Marra A, Blank N, Egenlauf B, Gorenflo M, Harutyunova S, Lorenz HM, Nagel C, Theobald V, Lichtblau M, Berlier C, Ulrich S, Grünig E, Benjamin N, Distler O.

Ann Rheum Dis. 2019 Dec 9. pii: annrheumdis-2019-216476. doi: 10.1136/annrheumdis-2019-216476. [Epub ahead of print]

PMID:
31818805
3.

Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort.

Mihai C, Distler O, Gheorghiu AM, Constantin PI, Dobrota R, Jordan S, Smith V, Hachulla E, Henes J, Siegert E, Vettori S, Müller-Ladner U, Matucci Cerinic M, Allanore Y; EUSTAR .

Rheumatology (Oxford). 2019 Dec 2. pii: kez558. doi: 10.1093/rheumatology/kez558. [Epub ahead of print]

PMID:
31790136
4.

Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study.

Jaeger VK, Tikly M, Xu D, Siegert E, Hachulla E, Airò P, Valentini G, Matucci Cerinic M, Distler O, Cozzi F, Carreira P, Allanore Y, Müller-Ladner U, Ananieva LP, Balbir-Gurman A, Distler JHW, Czirják L, Li M, Henes J, Jimenez SA, Smith V, Damjanov N, Denton CP, DelGaldo F, Saketkoo LA, Walker UA; EUSTAR co-authors .

Rheumatology (Oxford). 2019 Nov 4. pii: kez486. doi: 10.1093/rheumatology/kez486. [Epub ahead of print]

PMID:
31680161
5.

Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study).

Pan Z, Marra AM, Benjamin N, Eichstaedt CA, Blank N, Bossone E, Cittadini A, Coghlan G, Denton CP, Distler O, Egenlauf B, Fischer C, Harutyunova S, Xanthouli P, Lorenz HM, Grünig E.

Arthritis Res Ther. 2019 Oct 26;21(1):217. doi: 10.1186/s13075-019-1981-0.

6.

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. Reply.

Distler O, Gahlemann M, Maher TM.

N Engl J Med. 2019 Oct 17;381(16):1596-1597. doi: 10.1056/NEJMc1910735. No abstract available.

PMID:
31618556
7.

Does angiotensin and endothelin receptor blockade have an impact on lung function? An analysis from the EUSTAR database.

Radic M, Becker MO, Distler O, Huscher D, Siegert E, Riemekasten G; EUSTAR group.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):154-155. Epub 2019 Sep 26. No abstract available.

8.

Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease.

Distler O, Volkmann ER, Hoffmann-Vold AM, Maher TM.

Expert Rev Clin Immunol. 2019 Oct;15(10):1009-1017. doi: 10.1080/1744666X.2020.1668269. Epub 2019 Sep 30.

9.

Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern".

Smith V, Vanhaecke A, Herrick AL, Distler O, Guerra MG, Denton CP, Deschepper E, Foeldvari I, Gutierrez M, Hachulla E, Ingegnoli F, Kubo S, Müller-Ladner U, Riccieri V, Sulli A, van Laar JM, Vonk MC, Walker UA, Cutolo M; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Autoimmun Rev. 2019 Nov;18(11):102394. doi: 10.1016/j.autrev.2019.102394. Epub 2019 Sep 11.

10.

Experimental Mouse Model of Bleomycin-Induced Skin Fibrosis.

Błyszczuk P, Kozlova A, Guo Z, Kania G, Distler O.

Curr Protoc Immunol. 2019 Sep;126(1):e88. doi: 10.1002/cpim.88.

PMID:
31483105
11.

Might Nailfold Capillaroscopy Be a "Proxy" for Lung Involvement in Connective Tissue Diseases?

Smith V, Distler O, Cutolo M.

J Rheumatol. 2019 Sep;46(9):1061-1063. doi: 10.3899/jrheum.181408. No abstract available.

PMID:
31474612
12.

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual.

Fasano S, Riccardi A, Messiniti V, Caramaschi P, Rosato E, Maurer B, Smith V, Siegert E, De Langhe E, Riccieri V, Airó P, Mihai C, Avouac J, Zanatta E, Walker UA, Iannone F, García De la Peña Lefebvre P, Distler JHW, Vacca A, Distler O, Kowal-Bielecka O, Allanore Y, Valentini G.

Ann Rheum Dis. 2019 Dec;78(12):1681-1685. doi: 10.1136/annrheumdis-2019-215787. Epub 2019 Aug 17.

PMID:
31422354
13.

Identification and Isolation of Cardiac Fibroblasts From the Adult Mouse Heart Using Two-Color Flow Cytometry.

Stellato M, Czepiel M, Distler O, Błyszczuk P, Kania G.

Front Cardiovasc Med. 2019 Aug 1;6:105. doi: 10.3389/fcvm.2019.00105. eCollection 2019.

14.

Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study.

Valentini G, Huscher D, Riccardi A, Fasano S, Irace R, Messiniti V, Matucci-Cerinic M, Guiducci S, Distler O, Maurer B, Avouac J, Tarner IH, Frerix M, Riemekasten G, Siegert E, Czirják L, Lóránd V, Denton CP, Nihtyanova S, Walker UA, Jaeger VK, Del Galdo F, Abignano G, Ananieva LP, Gherghe AM, Mihai C, Henes JC, Schmeiser T, Vacca A, Moiseev S, Foeldvari I, Gabrielli A, Krummel-Lorenz B, Rednic S, Allanore Y, Müeller-Ladner U.

Ann Rheum Dis. 2019 Nov;78(11):1576-1582. doi: 10.1136/annrheumdis-2019-215486. Epub 2019 Aug 7.

PMID:
31391176
15.

Dipeptidyl-peptidase-4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in Systemic Sclerosis.

Soare A, Györfi HA, Matei AE, Dees C, Rauber S, Wohlfahrt T, Chen CW, Ludolph I, Horch RE, Bäuerle T, von Hörsten S, Mihai C, Distler O, Ramming A, Schett G, Distler JHW.

Arthritis Rheumatol. 2019 Jul 26. doi: 10.1002/art.41058. [Epub ahead of print]

PMID:
31350829
16.

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.

Khanna D, Spino C, Johnson S, Chung L, Whitfield ML, Denton CP, Berrocal V, Franks J, Mehta B, Molitor J, Steen VD, Lafyatis R, Simms RW, Gill A, Kafaja S, Frech TM, Hsu V, Domsic RT, Pope JE, Gordon JK, Mayes MD, Schiopu E, Young A, Sandorfi N, Park J, Hant FN, Bernstein EJ, Chatterjee S, Castelino FV, Ajam A, Wang Y, Wood T, Allanore Y, Matucci-Cerinic M, Distler O, Singer O, Bush E, Fox DA, Furst DE.

Arthritis Rheumatol. 2019 Jul 24. doi: 10.1002/art.41055. [Epub ahead of print]

PMID:
31342624
17.

Clinical and Echocardiographic Associates of All-Cause Mortality and Cardiovascular Outcomes in Patients With Systemic Sclerosis.

van Wijngaarden SE, Boonstra M, Bloem B, Cassani D, Tanner FC, Jordan S, Distler O, Delgado V, Bax JJ, de Vries-Bouwstra JK, Ajmone Marsan N.

JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2273-2276. doi: 10.1016/j.jcmg.2019.05.017. Epub 2019 Jul 17. No abstract available.

PMID:
31326475
18.

Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis.

Kozlova A, Pachera E, Maurer B, Jüngel A, Distler JHW, Kania G, Distler O.

Arthritis Rheumatol. 2019 Dec;71(12):2068-2080. doi: 10.1002/art.41041. Epub 2019 Nov 1.

PMID:
31309742
19.

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.

Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, Matucci-Cerinic M, de Oliveira Pena J, Pope JE, Distler O; EUSTAR Collaborators; EUSTAR Collaborators (numerical order of centres).

Ann Rheum Dis. 2019 Sep;78(9):1242-1248. doi: 10.1136/annrheumdis-2019-215145. Epub 2019 Jun 21.

20.

TET1 is an important transcriptional activator of TNFα expression in macrophages.

Sun F, Abreu-Rodriguez I, Ye S, Gay S, Distler O, Neidhart M, Karouzakis E.

PLoS One. 2019 Jun 19;14(6):e0218551. doi: 10.1371/journal.pone.0218551. eCollection 2019.

Supplemental Content

Loading ...
Support Center